Abstract
Noncompetitive N-methyl-d-aspartate receptor antagonists, including phencyclidine (PCP; also called angel dust), can cause abnormal behaviors. Among PCP-induced abnormal behaviors, we have focused on the mechanisms of hyperlocomotion and motor impairment. Studies have reported that serotonergic neurotoxin lesions of the median raphe nucleus induce significant enhancement of PCP-induced hyperlocomotion and higher levels of PCP-induced Fos immunoreactivity. Cortical cholinergic hypofunction also leads to enhanced PCP-induced locomotor activity. By contrast, ablation of the glutamate GluN2D subunit attenuates PCP-induced hyperlocomotion, behavioral sensitization, and motor impairment. The number of Fos-positive cells increases after PCP administration in the basal ganglia motor circuit in wild type mice but not in GluN2D knock out mice, suggesting that the GluN2D subunit within the motor circuitry is a key component of PCP-induced motor impairment. These results suggest that serotonergic, cholinergic, and glutamatergic innervations play important roles in PCP-induced abnormal behavior.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.